| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 03/18/1999 | WO1999012958A2 Ampullosporin, method for producing same and its use |
| 03/18/1999 | DE19740030A1 Ampullosporin, Verfahren zu dessen Herstellung und dessen Verwendung Ampullosporin, process for its preparation and its use |
| 03/18/1999 | CA2303462A1 Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerases |
| 03/18/1999 | CA2303422A1 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response |
| 03/18/1999 | CA2300221A1 Retro-inverso neurotrophic and analgesic peptides |
| 03/17/1999 | EP0902034A2 Very large scale immobilized peptide synthesis |
| 03/17/1999 | EP0901504A1 Zona pellucida proteins for contraception |
| 03/17/1999 | EP0779076A4 Peptide, a method of obtaining it and a pharmaceutical compound based on it |
| 03/17/1999 | EP0733065B1 Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases |
| 03/17/1999 | EP0728148B1 Improved immunogenic compositions against human gastrin 17 |
| 03/17/1999 | EP0616613B1 Fragments of prion proteins |
| 03/16/1999 | US5883293 Conformationally constrained backbone cyclized peptide analogs |
| 03/16/1999 | US5883076 Inducing plant defense mechanisms; wound healing agents; genetic engineering; gene expression |
| 03/16/1999 | US5883075 Hypotensive agent cyclic peptides |
| 03/16/1999 | US5882914 Nucleic acids encoding the hypoxia inducible factor-1 |
| 03/16/1999 | US5882907 Design of new ribozymes capable of self-catalyzed trans-splicing which are based upon the catalytic core of a group i intron are described |
| 03/16/1999 | CA2019463C Antibiotics plusbacin |
| 03/16/1999 | CA1340447C Pipecolic acid-containing peptolides, their preparation and pharmaceutical compositions containing them |
| 03/16/1999 | CA1340431C Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor |
| 03/11/1999 | WO1999011667A1 METHYLATED, SmD HOMOLOGOUS PEPTIDES, REACTIVE WITH THE ANTIBODIES FROM SERA OF LIVING BEINGS AFFECTED WITH SYSTEMIC LUPUS ERYTHEMATOSUS |
| 03/11/1999 | WO1999011590A1 Fluorination of proteins and peptides for f-18 positron emission tomography |
| 03/11/1999 | WO1999011282A1 Compositions and methods for contraception in or sterilization of mammals |
| 03/11/1999 | WO1998057986A3 Human preprotachykinin b |
| 03/11/1999 | WO1998045321A3 Peptide mimotopes for low molecular haptens, method for the production and use thereof |
| 03/10/1999 | EP0900384A2 Novel treatment |
| 03/10/1999 | EP0703783A4 Hla-a2.1 binding peptides and their uses |
| 03/10/1999 | CN1210110A Active peptide for promoting immunization function and usage thereof |
| 03/09/1999 | US5880267 Trophinin and trophinin-assisting protein agonists, antibodies and antagonists |
| 03/09/1999 | US5880259 Peptide useful as a ligand |
| 03/09/1999 | US5880095 Cholesteryl ester transfer protein inhibitor peptides and prophylactic and therapeutic anti-arteriosclerosis agents |
| 03/09/1999 | US5880092 Conformationally stabilized cell adhesion peptides |
| 03/09/1999 | US5879658 Technetium-99m labeled peptides for thrombus imaging |
| 03/09/1999 | US5879657 Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders |
| 03/09/1999 | US5879656 Radioactive therapeutic agent, receptor binding moiety |
| 03/04/1999 | WO1999010485A1 Methods using phage display for selecting internalizing ligands for gene delivery |
| 03/04/1999 | WO1999010382A1 Peptides which elicit cytotoxic t cellular immunity |
| 03/04/1999 | WO1999010379A1 Crystal of sm3 antibody (fragment) and recognizing epitope, its preparation, encoded data storage medium containing its coordinates and its diagnostical or medical use |
| 03/04/1999 | WO1999010378A1 Pompilid wasp-derived neuropeptides |
| 03/04/1999 | WO1999010374A1 Cyclosporin a conjugates and uses therefor |
| 03/04/1999 | WO1999010373A1 Non-immunosuppressive cyclosporins and their use in the prevention and treatment of hiv infection |
| 03/04/1999 | CA2302292A1 Methods using phage display for selecting internalizing ligands for gene delivery |
| 03/04/1999 | CA2301840A1 Peptides which elicit cytotoxic t cellular immunity |
| 03/04/1999 | CA2300370A1 Crystal of sm3 antibody (fragment) and recognizing epitope, its preparation, encoded data storage medium containing its coordinates and its diagnostical or medical use |
| 03/03/1999 | EP0898580A1 Methods and means for inhibition of cdk4 activity |
| 03/03/1999 | EP0677061B1 Polypeptides and anti-hiv agents prepared therefrom |
| 03/03/1999 | EP0537276B1 Cancer-associated scm-recognition factor, preparation and method of use |
| 03/03/1999 | CN1209876A Isolated tyrosinase derived peptides and uses thereof |
| 03/03/1999 | CN1209842A Nucleic acids encoding polypeptides having absidia lipase activity |
| 03/03/1999 | CN1209841A Biologically active and particularly peptide molecules having potentiating effect on growth hormone biological activity |
| 03/02/1999 | US5877294 Antigenic regions of tumor-liberated particles (TLP) complexes and antibodies against the same |
| 03/02/1999 | US5877282 Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof |
| 03/02/1999 | US5877278 Solid phase synthesis using two submonomers-an acylating agent, e.g. a haloacetic acid, and a primary amine; cyclization to produce mimetics of drugs; elimination of the necessity of protection groups |
| 03/02/1999 | US5877277 Octapeptide bombesin analogs |
| 03/02/1999 | US5877274 Antimicrobial cationic peptides |
| 03/02/1999 | US5877155 Exposure of platelets to the molecule (anti-mimotope) in order to modulate adhesion, aggregation, or agglutination of the platelets. |
| 03/02/1999 | US5877153 Heparin-binding peptides |
| 03/02/1999 | US5877151 Depending on the dose or concentration of endotoxin, the effects may either be deleterious or advantageous to the host. if excessive tnf-.alpha.,il-1, il-6, and il-8 are produced, they can evoke endotoxic (or septic) shock with symptoms |
| 03/02/1999 | US5877017 Isolated nucleic acid molecule encoding peptides which form complexes with MHC molecule HLA-Cw*1601 and uses thereof |
| 03/02/1999 | US5876965 Nucleic acid encoding ARF-19, a novel regulator of the mammalian cell cycle |
| 03/02/1999 | US5876948 Screening methods to identify neurotoxin inhibitors |
| 03/02/1999 | US5876748 Drug delivery |
| 03/02/1999 | US5876712 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
| 02/25/1999 | WO1998053050A3 Short peptides which selectively modulate the activity of serine/threonine kinases |
| 02/24/1999 | EP0897541A1 Identification and isolation of novel polypeptides having ww domains and methods of using same |
| 02/24/1999 | EP0897392A1 Isolation and use of sh3 binding peptides |
| 02/24/1999 | EP0760678A4 Quantitation of individual protein kinase activity |
| 02/24/1999 | EP0703900B1 PROCESS FOR THE PREPARATION OF PHENYLALANINE DERIVATIVES OR HOMOLOGUES CONTAINING A GUANIDINO OR MODIFIED GUANIDINO GROUP USEFUL FOR THE PREPARATION GnRH OF ANTAGONISTIC PEPTIDES |
| 02/23/1999 | US5874572 Process for preparing cyclosporin A |
| 02/23/1999 | US5874557 Enzyme inhibitors which bind to polymerases at ambient temperatures and prevent amplification of nontarget oligonucleotides during polymerase chain reactions; for accurate diagnosis |
| 02/23/1999 | US5874541 Immunoglobulin or fragment is modified such that heavy chain variable region have been replaced by specific sequence or amino acids of a heavy chain immunogloblin comprising two heavy polypeptide chain consisting of antigen binding site |
| 02/23/1999 | US5874531 Polypeptides implicated as self epitope in autoimmune disease pemphigus vulgaris and multiple scelerosis |
| 02/23/1999 | US5874529 Conformationally constrained backbone cyclized peptide analogs |
| 02/23/1999 | US5874414 Trans-splicing ribozymes |
| 02/23/1999 | US5874409 Antiphospholipid analog specifically binds antibodies produced by b cells specific for an antiphospholipid epitope and lacks t cell epitopes; where in the analog is a oligopeptide or polypeptide |
| 02/23/1999 | US5874403 Amino acid conjugates of cyclohexapeptidyl amines |
| 02/23/1999 | US5874401 Cedar pollen protein and use thereof in treating, preventing, and diagnosing pollenosis |
| 02/23/1999 | US5874400 Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor |
| 02/18/1999 | WO1999007874A1 Process for producing lh-rh derivatives |
| 02/18/1999 | WO1999007734A2 Hepatitis c inhibitor peptide analogues |
| 02/18/1999 | WO1999007733A2 Hepatitis c inhibitor peptides |
| 02/18/1999 | WO1999007729A2 Peptides having potassium channel opener activity |
| 02/18/1999 | WO1999007728A2 Linear peptides derived from antibiotic peptides, preparation and use for vectoring active substances |
| 02/18/1999 | WO1998014593A3 Human telomerase catalytic subunit |
| 02/18/1999 | CA2301669A1 Peptides having potassium channel opener activity |
| 02/18/1999 | CA2298932A1 Linear peptides derived from antibiotic peptides, preparation and use for vectoring active substances |
| 02/18/1999 | CA2294049A1 Hepatitis c inhibitor peptides |
| 02/17/1999 | EP0896615A1 Peptide from soluble form of acetylcholinesterase, active as a calcium channel modulator |
| 02/17/1999 | CN1208436A Novel polypeptide originating in hemophilus paragallinarum and process for producing the same |
| 02/16/1999 | US5872221 Capable of binding epitopes of pthrp and a kit for the detection of pthrp or fragments thereof comprising one or more antibody reagents capable of binding to epitopes of pthrp |
| 02/16/1999 | US5872218 Monoclonal antibodies |
| 02/16/1999 | US5872100 Peptides containing D-2-Alkyl-Tryptophan |
| 02/16/1999 | US5872097 Oligopeptides with affinity to opioid receptors |
| 02/16/1999 | US5871996 First agent comprising isolated virus having reverse transcriptase activity, second agent distinct from first, comprising nucleotides; both agents associated with multiple sclerosis and purifiable from viral isolate pol-2 and ms7pg |
| 02/16/1999 | US5871945 Modulators of anchoring protein function |
| 02/16/1999 | US5871933 Diagnosing, screening, and confirming infection with accuracy; vaccines |
| 02/16/1999 | US5871753 A compound comprising two or more multimerized ligands each independently selected from the group consisting of fk506, fk520 and cyclosporin, or macrocyclic derivatives thereof. |
| 02/16/1999 | US5871745 Isolated virus having reverse transcriptase activity, second agent distinct from first, comprising nucleotides; both agents associated with multiple sclerosis and purifiable from viral isolate pol-2 and ms7pg |
| 02/16/1999 | US5871712 Neurodegenerative condition, antiischemic agents and antibodies |
| 02/16/1999 | US5871711 Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses |
| 02/11/1999 | WO1999006599A1 Synthetic antigen for the detection of antibodies immunoreactive with hiv virus |